Fulgent Genetics, Inc. (FLGT) Tops Q1 EPS by $1.66, Lowers FY22 EPS Guidance

Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q1 EPS of $5.08, $1.66 better than the analyst estimate of $3.42. Revenue for the quarter came in at $320.3 million versus the consensus estimate of $244.65 million.

GUIDANCE:

Fulgent Genetics, Inc. sees FY2022 EPS of $6.00, versus the consensus of $7.00. Fulgent Genetics, Inc. sees FY2022 revenue of $660 million, versus the consensus of $650 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lands' End (LE) Tops Q1 EPS by 8c ; Offers Guidance
• Driven Brands (DRVN) Tops Q4 EPS by 2c, Misses on Revenue; Offers FY26 Guidance